Stuart J Wong

Summary

Affiliation: Medical College of Wisconsin
Country: USA

Publications

  1. doi request reprint A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia
    Stuart J Wong
    Medical College of Wisconsin, Milwaukee, Wisconsin, USA
    Oral Oncol 49:970-6. 2013
  2. doi request reprint Retreatment of recurrent head and neck cancer in a previously irradiated field
    Stuart J Wong
    Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA
    Semin Radiat Oncol 22:214-9. 2012
  3. doi request reprint Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN): analysis of chemoradiation treatment approaches in the United States
    Stuart J Wong
    Department of Neoplastic Diseases, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA
    Cancer 117:1679-86. 2011
  4. ncbi request reprint Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone?
    Stuart J Wong
    Division of Neoplastic Diseases, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    J Clin Oncol 24:2653-8. 2006
  5. doi request reprint Comparison of physical examination and fluorodeoxyglucose positron emission tomography/computed tomography 4-6 months after radiotherapy to assess residual head-and-neck cancer
    M Tracy Zundel
    Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI 53045, USA
    Int J Radiat Oncol Biol Phys 81:e825-32. 2011
  6. doi request reprint A phase II study of lapatinib in recurrent/metastatic squamous cell carcinoma of the head and neck
    Jonas A de Souza
    Section of Hematology Oncology, Department of Medicine, The University of Chicago Medical Center, Chicago, Illinois, USA
    Clin Cancer Res 18:2336-43. 2012
  7. pmc Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study
    Ezra E W Cohen
    Section of Hematology Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA University of Chicago Cancer Research Center, Chicago, IL, USA
    Lancet Oncol 10:247-57. 2009
  8. pmc Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer
    Stuart J Wong
    Medical College of Wisconsin, Milwaukee, WI, USA
    Int J Radiat Oncol Biol Phys 82:1367-75. 2012
  9. doi request reprint Clinical outcomes of patients receiving integrated PET/CT-guided radiotherapy for head and neck carcinoma
    Matthew R Vernon
    Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    Int J Radiat Oncol Biol Phys 70:678-84. 2008
  10. pmc Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214
    Elizabeth M Gore
    Department of Radiation Oncology, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI 53213, USA
    J Clin Oncol 29:272-8. 2011

Research Grants

Detail Information

Publications11

  1. doi request reprint A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia
    Stuart J Wong
    Medical College of Wisconsin, Milwaukee, Wisconsin, USA
    Oral Oncol 49:970-6. 2013
    ..We conducted a phase I study to determine MTD and DLT of PDT in patients treated with ALA for leukoplakia...
  2. doi request reprint Retreatment of recurrent head and neck cancer in a previously irradiated field
    Stuart J Wong
    Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA
    Semin Radiat Oncol 22:214-9. 2012
    ..Analysis of recent reRT studies points out areas where incremental advances have been made, but more importantly, we provide a guide to the priorities on which future investigations should focus...
  3. doi request reprint Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN): analysis of chemoradiation treatment approaches in the United States
    Stuart J Wong
    Department of Neoplastic Diseases, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA
    Cancer 117:1679-86. 2011
    ..A study was undertaken to examine the patterns of systemic therapy use in conjunction with radiation therapy for patients with locally advanced head and neck squamous cell cancer...
  4. ncbi request reprint Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone?
    Stuart J Wong
    Division of Neoplastic Diseases, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    J Clin Oncol 24:2653-8. 2006
    ....
  5. doi request reprint Comparison of physical examination and fluorodeoxyglucose positron emission tomography/computed tomography 4-6 months after radiotherapy to assess residual head-and-neck cancer
    M Tracy Zundel
    Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI 53045, USA
    Int J Radiat Oncol Biol Phys 81:e825-32. 2011
    ..To retrospectively compare fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) and physical examination 4-6 months after radiotherapy for assessing residual head-and-neck cancer (HNC)...
  6. doi request reprint A phase II study of lapatinib in recurrent/metastatic squamous cell carcinoma of the head and neck
    Jonas A de Souza
    Section of Hematology Oncology, Department of Medicine, The University of Chicago Medical Center, Chicago, Illinois, USA
    Clin Cancer Res 18:2336-43. 2012
    ..This study sought to determine the efficacy and safety profile of lapatinib in patients with recurrent/metastatic squamous cell carcinoma of the head and neck (SCCHN)...
  7. pmc Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study
    Ezra E W Cohen
    Section of Hematology Oncology, Department of Medicine, University of Chicago, Chicago, IL, USA University of Chicago Cancer Research Center, Chicago, IL, USA
    Lancet Oncol 10:247-57. 2009
    ..In this multi-institutional phase I/II study we combined an EGFR inhibitor, erlotinib, with an anti-VEGF antibody, bevacizumab...
  8. pmc Radiation Therapy Oncology Group 0247: a randomized Phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer
    Stuart J Wong
    Medical College of Wisconsin, Milwaukee, WI, USA
    Int J Radiat Oncol Biol Phys 82:1367-75. 2012
    ..To evaluate the rate of pathologic complete response (pCR) and the toxicity of two neoadjuvant chemoradiotherapy (chemoRT) regimens for Stage T3-T4 rectal cancer in a randomized Phase II study...
  9. doi request reprint Clinical outcomes of patients receiving integrated PET/CT-guided radiotherapy for head and neck carcinoma
    Matthew R Vernon
    Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI 53226, USA
    Int J Radiat Oncol Biol Phys 70:678-84. 2008
    ..The purpose of this study was to evaluate clinical outcomes and the predictive value of PET for patients receiving PET/CT-guided definitive radiotherapy with or without chemotherapy...
  10. pmc Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214
    Elizabeth M Gore
    Department of Radiation Oncology, Medical College of Wisconsin, 9200 W Wisconsin Ave, Milwaukee, WI 53213, USA
    J Clin Oncol 29:272-8. 2011
    ..This study was conducted to determine if prophylactic cranial irradiation (PCI) improves survival in locally advanced non-small-cell lung cancer (LA-NSCLC)...
  11. ncbi request reprint Oxaliplatin hypersensitivity: case report and successful repeat desensitization
    David A Edmondson
    Allergy and Immunology Ear, Nose, and Throat Associates of North Central Wisconsin, Wausau, WI 54401, USA
    Am J Ther 14:116-8. 2007
    ..Desensitization protocols for oxaliplatin with premedication using steroids or antihistamines have been previously reported. We present a patient who underwent successful repeat desensitization without premedication...

Research Grants1

  1. Molecular Characterization of p53R2 in Head and Neck Ca
    Stuart Wong; Fiscal Year: 2004
    ..We will identify and characterize the frequency of p53R2 gene SNPs in HNSCC patients and test the hypothesis that p53R2 gene SNPs predict adverse normal tissue radiation effects in HNSCC patients treated with radiation. ..